PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Natalie Yeadon

      Natalie Yeadon

      Health literacy in the time of COVID-19

      A version of this article was previously published on Pharmaphorum. In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and...
      Natalie Yeadon -
      Natalie Yeadon

      Top-10 ways that Pharma teams can fight the climate crisis

      Two years ago, I first wrote about why Pharma should care about global warming. Since then, there have been some signs of more companies...
      Natalie Yeadon -
      Natalie Yeadon

      Alzheimer’s Researchers Release Free Apps to Track Memory and Cognition

      Alzheimer's Disease Researchers at California based Leucadia Therapeutics released a panel of eight apps today to help people track memory and cognition. The new apps...
      Margaretta Colangelo -
      Natalie Yeadon

      Gamification for patient care, medical education, and virtual engagement

      A version of this article was previously published on Pharmaphorum. “Gamification”–adding game-like elements into non-game or real-world settings–has become a popular concept in the pharmaceutical,...
      Natalie Yeadon -
      Natalie Yeadon

      Top 10 Tips to Increase Engagement During Virtual Events

      If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted...
      Natalie Yeadon -
      Natalie Yeadon

      Top 10 Tips for Running a Successful Virtual Event

      The ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms...
      Natalie Yeadon -
      123...6Page 1 of 6

      Recent Articles

      Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

      Editor´s Pick

      Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

      Regulatory Affairs

      bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood...

      Industry News

      LabGenius Appoints Dr. Didier Landais as Chief Operating Officer

      Look Who’s On the Move!

      Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries

      Editor´s Pick

      Taysha Receives Orphan Drug Designation from the European Commission for TSHA-102 for the Treatment of Rett Syndrome

      Look Who’s On the Move!

      Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

      Look Who’s On the Move!

      Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine...

      Industry News

      Dicerna Announces New Executive Leadership Appointments

      Look Who’s On the Move!

      Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021

      Industry News

      CG Oncology and Roche to Collaborate on Clinical Trial of Oncolytic Immunotherapy CG0070 as Part of Novel Combination for Various Solid Tumor Indications

      Industry News

      Vividion Therapeutics Announces Formation of Scientific Advisory Board

      Industry News

      Ocular Therapeutix™ Appoints Merilee Raines to Its Board of Directors

      Look Who’s On the Move!

      AnHeart Therapeutics Announces Formation of Scientific Advisory Board

      Look Who’s On the Move!

      Peptilogics to Present First-in-Human Phase 1 Clinical Data of PLG0206 at IDWeek 2021

      Industry News

      2021 © Copyright - TPMG